Despite advancements in our understanding of Alzheimer’s disease, critical bottlenecks remain. As ADPD2025 begins, leaders from academia, industry, and healthcare have come together with a resounding message: artificial intelligence has profound potential to overcome obstacles in Alzheimer’s research.
Read more in Nature Portfolio as they outline four immediate priorities to catalyze and integrate AI into.